Carboplatin And Doxil For Recurrent Ovarian Cancer
AGO-OVAR 2.29/ENGOT-ov34: atezolizumab vs placebo + bevacizumab w/ chemo recurrent ovarian cancer Carboplatin and Liposomal Doxorubicin for Ovarian Cancer - PMC Amina Ahmed, MD, presents the case of a 56-year-old woman diagnosed with stage IV ovarian cancer and discusses the initial Michael J. Birrer, MD, PhD, director, Massaschusetts General Hospital Cancer Center, gynecologic medical oncology, discusses ...